Outcomes of total hip arthroplasty in patients with primary immune thrombocytopenia
Open Access
- 5 October 2015
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 16 (1) , 1-7
Abstract
Immune thrombocytopenia (ITP) is an immune-mediated acquired disease that is characterized by a decrease in the platelet count and an increased risk of bleeding. There is little information in the literature about the results of major joint replacement surgery in patients with ITP. The aim of this study was to report on the results of total hip arthroplasty (THA) in patients with primary ITP. We retrospectively identified 15 THAs performed in 11 patients with primary ITP. The study group was matched (1:2) to a non-ITP control group of 30 THAs in 22 patients. According to the perioperative hematologic evaluation, blood management interventions were performed. All procedures were performed by a single surgeon and all patients received cementless components with ceramic-on-ceramic bearing. Mean duration of follow-up was 7.1 years (range, 2–13). No significant differences were found between the two groups with regard to mean operative time, intraoperative blood loss, amount of closed suction drainage, length of hospital stay, and readmission rate. However, the proportion of patients requiring transfusion of packed red blood cells and/or platelet concentrate was higher in the ITP group when compared to the non-ITP group. Mean Harris hip score improved from 49.5 points preoperatively to 93.4 points at the final follow-up and no hips were revised for loosening or osteolysis in the ITP group. No significant differences were found between the two groups with respect to mean postoperative Harris hip scores and complication rates. Our study showed encouraging clinical and radiographic results of THA in patients with ITP without increased risk of adverse events compared to those in patients without ITP. On the basis of these findings, we suggest that modern cementless THA might be a viable treatment for achieving functional improvement in patients with ITP and end-stage hip disease.Keywords
This publication has 26 references indexed in Scilit:
- Perioperative Care of a Patient with Refractory Idiopathic Thrombocytopenic Purpura Undergoing Total Knee ArthroplastyKnee Surgery & Related Research, 2012
- Eleven- to 14-year Follow-up Results of Cementless Total Hip Arthroplasty Using a Third-generation Alumina Ceramic-on-ceramic BearingThe Journal of Arthroplasty, 2012
- Glucocorticoid-Induced Bone DiseaseNew England Journal of Medicine, 2011
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopeniaBlood, 2011
- Temporal trends in primary total hip and knee arthroplasty surgery: results from a UK regional joint register, 1991–2004The Annals of The Royal College of Surgeons of England, 2010
- International consensus report on the investigation and management of primary immune thrombocytopeniaBlood, 2010
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgeryTransfusion, 2009
- Nerve-root injections for the relief of pain in patients with osteoporotic vertebral fracturesThe Journal of Bone and Joint Surgery. British volume, 2003
- Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancyBritish Journal of Haematology, 2003